late
decemb
cluster
case
viral
pneumonia
link
seafood
market
wuhan
hubei
china
later
determin
caus
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
previous
known
genom
sequenc
similar
distinct
two
coronavirus
respons
largescal
outbreak
past
sever
acut
respiratori
syndrom
coronaviru
sarscov
sequenc
ident
middl
east
respiratori
syndrom
coronaviru
merscov
ct
import
imag
modal
assist
diagnosi
manag
patient
coronaviru
diseas
pneumonia
report
radiolog
appear
pneumonia
emerg
lancet
infecti
diseas
heshui
shi
colleagu
discuss
ct
fi
nding
tempor
chang
pneumonia
refer
time
onset
symptom
largest
cohort
thu
far
report
predomin
ct
fi
nding
includ
groundglass
opacifi
cation
consolid
bila
teral
involv
ment
peripher
diff
use
distribut
fi
nding
concur
report
smaller
cohort
experi
notabl
shi
colleagu
studi
asymptomat
subclin
group
patient
show
earli
ct
chang
support
fi
rst
observ
famili
cluster
pneumonia
convers
studi
shown
posit
rtpcr
result
absenc
ct
chang
abnorm
ct
fi
nding
initi
falseneg
rtpcr
result
epidem
evolv
start
observ
vari
present
pneumonia
symptomat
patient
show
con
cordant
ct
rtpcr
fi
nding
nevertheless
small
number
individu
pneumonia
pose
diagnost
dilemma
given
vari
manifest
evolut
diseas
ct
well
understood
shi
colleagu
report
presenc
unilater
groundglass
opac
subgroup
asymptomat
patient
pneumonia
substanti
previou
anecdot
report
asymptomat
patient
could
ct
chang
symptom
onset
fi
nding
suggest
ct
sensit
modal
detect
pneumonia
even
asymptomat
individu
could
consid
screen
tooltogeth
rtpcrwhen
patient
signifi
cant
travel
histori
close
contact
infect
individu
furthermor
ct
might
particularli
import
screen
tool
small
proport
patient
falseneg
rtpcr
result
shi
colleagu
also
show
lesion
present
asymptomat
individu
progress
bilater
diff
use
diseas
consolid
around
fi
rst
second
week
symptom
onset
hubei
surg
diagnos
feb
introduct
new
diagnost
criteria
includ
ct
chang
criteria
employ
ensur
time
treatment
isol
measur
delay
associ
laboratori
test
larg
number
patient
present
respiratori
symptom
provinc
predomin
pattern
seen
pneu
monia
groundglass
opacifi
cation
detect
use
chest
radiographyon
type
abnorm
often
imperceiv
particularli
patient
symptom
low
severityi
like
challeng
contrast
chest
radiograph
use
frequent
diagnosi
sar
groundglass
opacifi
cation
consolid
present
earli
current
literatur
partli
skew
geograph
distribut
pneumonia
preferenti
use
ct
chest
radiograph
china
prefer
might
due
eas
access
ct
china
lack
requir
intraven
contrast
agent
examin
therefor
unclear
whether
threshold
perform
ct
evalu
potenti
lung
chang
lower
chest
radiograph
normal
research
need
better
select
patient
ct
examin
defi
ne
util
ct
pneumonia
explor
applic
artifi
cial
intellig
screen
chest
radiograph
suspect
case
overal
congratul
shi
colleagu
ad
valuabl
inform
current
literatur
author
care
evalu
ct
fi
nding
influenza
vaccineprevent
diseas
caus
constantli
mutat
viru
mean
vaccin
composit
must
updat
almost
everi
year
burden
season
influenza
high
emerg
pandem
viru
caus
substanti
damag
popul
healthcar
system
pandem
start
demand
specif
vaccin
soar
lead
global
shortag
one
possibl
approach
solv
problem
offer
new
technolog
base
nonrepl
adenoviru
viral
vector
approach
assess
phase
studi
david
liebowitz
colleagu
lancet
infecti
diseas
oral
deliv
adenovirusvector
vaccin
produc
use
eggindepend
technolog
requir
specif
equip
syring
needl
spray
devic
thu
produc
less
potenti
biohazard
wast
inject
nasal
vaccin
addit
highli
stabl
ambient
temperatur
allow
distribut
administ
quickli
author
report
result
phase
studi
healthi
adult
vaccin
show
except
safeti
immunogen
profil
induc
high
influenza
virusspecif
haemagglutin
inhibit
hai
micro
neutra
lisat
antibodi
titr
singl
dose
present
studi
liebowitz
colleagu
establish
efficaci
vaccin
also
attempt
identifi
immun
correl
protect
human
challeng
studi
compar
licens
quadrival
splitvirion
inactiv
influenza
vaccin
iiv
challeng
viru
administ
day
immunis
reflect
real
interv
season
vaccin
campaign
annual
influenza
epidem
although
induc
sub
stantial
lower
antihaemagglutinin
serum
antibodi
titr
iiv
vaccin
show
overal
similar
protect
efficaci
challeng
viru
hai
geometr
mean
titr
day
vaccin
group
vs
iiv
group
data
suggest
vaccin
distinct
immun
correl
larg
cohort
patient
pneumonia
provid
indirect
evid
evolut
ct
chang
refer
onset
symptom
learnt
novel
contagi
viral
pneumonia
research
need
correl
ct
find
clinic
sever
progress
predict
valu
baselin
ct
tempor
chang
diseas
outcom
sequela
acut
lung
injuri
induc
declar
compet
interest
